CHEMDIV AND EUROSCREEN FORM STRATEGIC ALLIANCE

ChemDiv and Euroscreen announced their partnership in the discovery and development of drug candidates against a panel of chemokine receptors, a specific subset of G Protein Coupled-Receptor (GPCR) targets involved in inflammation, immunomodulation, and carcinogenesis. ChemDiv will contribute its expertise in both synthetic and medicinal chemistry, whereas Euroscreen will develop respective GPCR assays and insure the screening and general molecular biology support of this joint venture.

DrugNewswire (http://www.drugnewswire.com/902/)